Click for best price
Small Molecule Targeted Anticancer Drug Market Size, Share 2022
This report contains market size and forecasts of Small Molecule Targeted Anti-cancer Drug in Global, including the following market information:
Global Small Molecule Targeted Anti-cancer Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Small Molecule Targeted Anti-cancer Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
EGFR Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Small Molecule Targeted Anti-cancer Drug include Astrazeneca, Novartis, Millennium Pharmaceuticals, Bayer, Exelixis, Abbvie, Boehringer-Ingelheim, Eisai and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Small Molecule Targeted Anti-cancer Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Small Molecule Targeted Anti-cancer Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Small Molecule Targeted Anti-cancer Drug Market Segment Percentages, by Type, 2021 (%)
EGFR
ALK
Bcr-Abl
Others
Global Small Molecule Targeted Anti-cancer Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Small Molecule Targeted Anti-cancer Drug Market Segment Percentages, by Application, 2021 (%)
Liver Cancer
Colorectal Cancer
Lung Cancer
Gastric Cancer
Breast Cancer
Esophageal Cancer
Others
Global Small Molecule Targeted Anti-cancer Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Small Molecule Targeted Anti-cancer Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Small Molecule Targeted Anti-cancer Drug revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Small Molecule Targeted Anti-cancer Drug revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Astrazeneca
Novartis
Millennium Pharmaceuticals
Bayer
Exelixis
Abbvie
Boehringer-Ingelheim
Eisai
Pfizer
Bristol-Myers Squibb
Roche
Bettapharma
| Report Attributes |
Report Details |
| Report Title |
Small Molecule Targeted Anti-cancer Drug Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
60 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Small Molecule Targeted Anti-cancer Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Small Molecule Targeted Anti-cancer Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Small Molecule Targeted Anti-cancer Drug Overall Market Size
2.1 Global Small Molecule Targeted Anti-cancer Drug Market Size: 2021 VS 2028
2.2 Global Small Molecule Targeted Anti-cancer Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Small Molecule Targeted Anti-cancer Drug Players in Global Market
3.2 Top Global Small Molecule Targeted Anti-cancer Drug Companies Ranked by Revenue
3.3 Global Small Molecule Targeted Anti-cancer Drug Revenue by Companies
3.4 Top 3 and Top 5 Small Molecule Targeted Anti-cancer Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Small Molecule Targeted Anti-cancer Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Small Molecule Targeted Anti-cancer Drug Players in Global Market
3.6.1 List of Global Tier 1 Small Molecule Targeted Anti-cancer Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Small Molecule Targeted Anti-cancer Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Small Molecule Targeted Anti-cancer Drug Market Size Markets, 2021 & 2028
4.1.2 EGFR
4.1.3 ALK
4.1.4 Bcr-Abl
4.1.5 Others
4.2 By Type - Global Small Molecule Targeted Anti-cancer Drug Revenue & Forecasts
4.2.1 By Type - Global Small Molecule Targeted Anti-cancer Drug Revenue, 2017-2022
4.2.2 By Type - Global Small Molecule Targeted Anti-cancer Drug Revenue, 2023-2028
4.2.3 By Type - Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Small Molecule Targeted Anti-cancer Drug Market Size, 2021 & 2028
5.1.2 Liver Cancer
5.1.3 Colorectal Cancer
5.1.4 Lung Cancer
5.1.5 Gastric Cancer
5.1.6 Breast Cancer
5.1.7 Esophageal Cancer
5.1.8 Others
5.2 By Application - Global Small Molecule Targeted Anti-cancer Drug Revenue & Forecasts
5.2.1 By Application - Global Small Molecule Targeted Anti-cancer Drug Revenue, 2017-2022
5.2.2 By Application - Global Small Molecule Targeted Anti-cancer Drug Revenue, 2023-2028
5.2.3 By Application - Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Small Molecule Targeted Anti-cancer Drug Market Size, 2021 & 2028
6.2 By Region - Global Small Molecule Targeted Anti-cancer Drug Revenue & Forecasts
6.2.1 By Region - Global Small Molecule Targeted Anti-cancer Drug Revenue, 2017-2022
6.2.2 By Region - Global Small Molecule Targeted Anti-cancer Drug Revenue, 2023-2028
6.2.3 By Region - Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Small Molecule Targeted Anti-cancer Drug Revenue, 2017-2028
6.3.2 US Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.3.3 Canada Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.3.4 Mexico Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Small Molecule Targeted Anti-cancer Drug Revenue, 2017-2028
6.4.2 Germany Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.4.3 France Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.4.4 U.K. Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.4.5 Italy Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.4.6 Russia Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.4.7 Nordic Countries Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.4.8 Benelux Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Small Molecule Targeted Anti-cancer Drug Revenue, 2017-2028
6.5.2 China Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.5.3 Japan Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.5.4 South Korea Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.5.5 Southeast Asia Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.5.6 India Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Small Molecule Targeted Anti-cancer Drug Revenue, 2017-2028
6.6.2 Brazil Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.6.3 Argentina Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Small Molecule Targeted Anti-cancer Drug Revenue, 2017-2028
6.7.2 Turkey Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.7.3 Israel Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.7.4 Saudi Arabia Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.7.5 UAE Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
7 Players Profiles
7.1 Astrazeneca
7.1.1 Astrazeneca Corporate Summary
7.1.2 Astrazeneca Business Overview
7.1.3 Astrazeneca Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.1.4 Astrazeneca Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2017-2022)
7.1.5 Astrazeneca Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.2.4 Novartis Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2017-2022)
7.2.5 Novartis Key News
7.3 Millennium Pharmaceuticals
7.3.1 Millennium Pharmaceuticals Corporate Summary
7.3.2 Millennium Pharmaceuticals Business Overview
7.3.3 Millennium Pharmaceuticals Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.3.4 Millennium Pharmaceuticals Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2017-2022)
7.3.5 Millennium Pharmaceuticals Key News
7.4 Bayer
7.4.1 Bayer Corporate Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.4.4 Bayer Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2017-2022)
7.4.5 Bayer Key News
7.5 Exelixis
7.5.1 Exelixis Corporate Summary
7.5.2 Exelixis Business Overview
7.5.3 Exelixis Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.5.4 Exelixis Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2017-2022)
7.5.5 Exelixis Key News
7.6 Abbvie
7.6.1 Abbvie Corporate Summary
7.6.2 Abbvie Business Overview
7.6.3 Abbvie Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.6.4 Abbvie Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2017-2022)
7.6.5 Abbvie Key News
7.7 Boehringer-Ingelheim
7.7.1 Boehringer-Ingelheim Corporate Summary
7.7.2 Boehringer-Ingelheim Business Overview
7.7.3 Boehringer-Ingelheim Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.7.4 Boehringer-Ingelheim Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2017-2022)
7.7.5 Boehringer-Ingelheim Key News
7.8 Eisai
7.8.1 Eisai Corporate Summary
7.8.2 Eisai Business Overview
7.8.3 Eisai Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.8.4 Eisai Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2017-2022)
7.8.5 Eisai Key News
7.9 Pfizer
7.9.1 Pfizer Corporate Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.9.4 Pfizer Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2017-2022)
7.9.5 Pfizer Key News
7.10 Bristol-Myers Squibb
7.10.1 Bristol-Myers Squibb Corporate Summary
7.10.2 Bristol-Myers Squibb Business Overview
7.10.3 Bristol-Myers Squibb Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.10.4 Bristol-Myers Squibb Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2017-2022)
7.10.5 Bristol-Myers Squibb Key News
7.11 Roche
7.11.1 Roche Corporate Summary
7.11.2 Roche Business Overview
7.11.3 Roche Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.11.4 Roche Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2017-2022)
7.11.5 Roche Key News
7.12 Bettapharma
7.12.1 Bettapharma Corporate Summary
7.12.2 Bettapharma Business Overview
7.12.3 Bettapharma Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.12.4 Bettapharma Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2017-2022)
7.12.5 Bettapharma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Small Molecule Targeted Anti-cancer Drug Market Opportunities & Trends in Global Market
Table 2. Small Molecule Targeted Anti-cancer Drug Market Drivers in Global Market
Table 3. Small Molecule Targeted Anti-cancer Drug Market Restraints in Global Market
Table 4. Key Players of Small Molecule Targeted Anti-cancer Drug in Global Market
Table 5. Top Small Molecule Targeted Anti-cancer Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Small Molecule Targeted Anti-cancer Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Small Molecule Targeted Anti-cancer Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Small Molecule Targeted Anti-cancer Drug Product Type
Table 9. List of Global Tier 1 Small Molecule Targeted Anti-cancer Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Small Molecule Targeted Anti-cancer Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Small Molecule Targeted Anti-cancer Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Small Molecule Targeted Anti-cancer Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Small Molecule Targeted Anti-cancer Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Small Molecule Targeted Anti-cancer Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2023-2028
Table 30. Astrazeneca Corporate Summary
Table 31. Astrazeneca Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 32. Astrazeneca Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Corporate Summary
Table 34. Novartis Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 35. Novartis Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn), (2017-2022)
Table 36. Millennium Pharmaceuticals Corporate Summary
Table 37. Millennium Pharmaceuticals Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 38. Millennium Pharmaceuticals Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn), (2017-2022)
Table 39. Bayer Corporate Summary
Table 40. Bayer Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 41. Bayer Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn), (2017-2022)
Table 42. Exelixis Corporate Summary
Table 43. Exelixis Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 44. Exelixis Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn), (2017-2022)
Table 45. Abbvie Corporate Summary
Table 46. Abbvie Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 47. Abbvie Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn), (2017-2022)
Table 48. Boehringer-Ingelheim Corporate Summary
Table 49. Boehringer-Ingelheim Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 50. Boehringer-Ingelheim Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn), (2017-2022)
Table 51. Eisai Corporate Summary
Table 52. Eisai Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 53. Eisai Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn), (2017-2022)
Table 54. Pfizer Corporate Summary
Table 55. Pfizer Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 56. Pfizer Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn), (2017-2022)
Table 57. Bristol-Myers Squibb Corporate Summary
Table 58. Bristol-Myers Squibb Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 59. Bristol-Myers Squibb Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn), (2017-2022)
Table 60. Roche Corporate Summary
Table 61. Roche Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 62. Roche Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn), (2017-2022)
Table 63. Bettapharma Corporate Summary
Table 64. Bettapharma Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 65. Bettapharma Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Small Molecule Targeted Anti-cancer Drug Segment by Type in 2021
Figure 2. Small Molecule Targeted Anti-cancer Drug Segment by Application in 2021
Figure 3. Global Small Molecule Targeted Anti-cancer Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Small Molecule Targeted Anti-cancer Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Small Molecule Targeted Anti-cancer Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Small Molecule Targeted Anti-cancer Drug Revenue in 2021
Figure 8. By Type - Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2017-2028
Figure 12. US Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2017-2028
Figure 16. Germany Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2017-2028
Figure 24. China Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Astrazeneca Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Millennium Pharmaceuticals Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bayer Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Exelixis Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Abbvie Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Boehringer-Ingelheim Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Eisai Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Pfizer Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Bristol-Myers Squibb Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Roche Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Bettapharma Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
